Critical Care Reviews Meeting 2020

The meeting has added two major clinical trials to its programme for early 2020. 
Firstly, the ANZICS Clinical Trials Group PEPTIC trial, comparing proton pump inhibitors with histamine 2 receptor blockers in mechanically ventilated ICU patients. This huge multi-centre, cluster randomised, crossover, registry trial has recruited 26,733 patients.
Secondly VITAMINS, another great ANZICS trial, to the CCR20 programme. This phase IIb trial investigates vitamin C, thiamine and hydrocortisone in patients with septic shock. It will be presented by Dr Tomoko Fujii from Melbourne.
Registration for CCR20 is open with details available via this link.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s